<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.molecularbrain.com/feeds/mostaccessed/journal?quantity=&amp;format=rss&amp;version=">
        <title>Molecular Brain - Most accessed articles</title>
        <link>http://www.molecularbrain.com</link>
        <description>The most accessed research articles published by Molecular Brain</description>
        <dc:date>2012-02-02T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.molecularbrain.com/content/4/1/31" />
                                <rdf:li rdf:resource="http://www.molecularbrain.com/content/5/1/1" />
                                <rdf:li rdf:resource="http://www.molecularbrain.com/content/4/1/3" />
                                <rdf:li rdf:resource="http://www.molecularbrain.com/content/4/1/38" />
                                <rdf:li rdf:resource="http://www.molecularbrain.com/content/1/1/6" />
                                <rdf:li rdf:resource="http://www.molecularbrain.com/content/5/1/3" />
                                <rdf:li rdf:resource="http://www.molecularbrain.com/content/4/1/44" />
                                <rdf:li rdf:resource="http://www.molecularbrain.com/content/4/1/43" />
                                <rdf:li rdf:resource="http://www.molecularbrain.com/content/5/1/5" />
                                <rdf:li rdf:resource="http://www.molecularbrain.com/content/5/1/2" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.molecularbrain.com/content/4/1/31">
        <title>Neuronal and microglial mechanisms of neuropathic pain</title>
        <description>Neuropathic pain is generally defined as a chronic pain state resulting from peripheral and/or central nerve injury. Effective treatment for neuropathic pain is still lacking, due in part to poor understanding of pathological mechanisms at the molecular level. Neuronal mechanisms of neuropathic pain, especially synaptic plasticity, are the major focus of many investigators. N-methyl-D-aspartate (NMDA) receptor dependent synaptic plasticity at the spinal and cortical levels is believed to contribute to enhanced sensory responses after injury. Glial cells, including astrocytes and microglia, have recently been implicated in neuropathic pain. These glial cells form close interactions with neurons and thus may modulate nociceptive transmission under pathological conditions. In this review, we present recent progress in the study of neuronal and microglial mechanisms underlying neuropathic pain. We propose that activity-dependent neuronal plasticity is a key target for treatment in neuropathic pain.</description>
        <link>http://www.molecularbrain.com/content/4/1/31</link>
                <dc:creator>Min Zhuo</dc:creator>
                <dc:creator>Gongxiong Wu</dc:creator>
                <dc:creator>Long-Jun Wu</dc:creator>
                <dc:source>Molecular Brain 2011, null:31</dc:source>
        <dc:date>2011-07-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-6606-4-31</dc:identifier>
                                <prism:require>/content/figures/1756-6606-4-31-toc.gif</prism:require>
                <prism:publicationName>Molecular Brain</prism:publicationName>
        <prism:issn>1756-6606</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>31</prism:startingPage>
        <prism:publicationDate>2011-07-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.molecularbrain.com/content/5/1/1">
        <title>NMDA Receptor Activation Stimulates Transcription-Independent Rapid Wnt5a Protein Synthesis via the MAPK Signaling Pathway</title>
        <description>Wnt proteins are emerging key regulators of the plasticity and functions of adult brains. However, the mechanisms by which the expression of Wnt proteins is regulated in neurons are unclear. Using primary cortical cultures, we show that activation of NMDA receptors (NMDARs) induces rapid Wnt5a protein synthesis. This NMDAR-regulated Wnt5a synthesis does not require transcription and is a result of activity-dependent translation. We also show that NMDAR-regulated Wnt5a translation depends on MAPK signaling but not mTOR signaling. Our findings suggest that the synaptic activity of CNS neurons activates NMDARs, which in turn stimulate translation from stored Wnt5a mRNA via the MAPK signaling pathway.</description>
        <link>http://www.molecularbrain.com/content/5/1/1</link>
                <dc:creator>Yichen Li</dc:creator>
                <dc:creator>Bei Li</dc:creator>
                <dc:creator>Xianzi Wan</dc:creator>
                <dc:creator>Wei Zhang</dc:creator>
                <dc:creator>Ling Zhong</dc:creator>
                <dc:creator>Shao-Jun Tang</dc:creator>
                <dc:source>Molecular Brain 2012, null:1</dc:source>
        <dc:date>2012-01-04T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-6606-5-1</dc:identifier>
                                <prism:require>/content/figures/1756-6606-5-1-toc.gif</prism:require>
                <prism:publicationName>Molecular Brain</prism:publicationName>
        <prism:issn>1756-6606</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2012-01-04T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.molecularbrain.com/content/4/1/3">
        <title>APP Processing in Alzheimer&apos;s Disease</title>
        <description>An important pathological feature of Alzheimer&apos;s disease (AD) is the presence of extracellular senile plaques in the brain. Senile plaques are composed of aggregations of small peptides called &#946;-amyloid (A&#946;). Multiple lines of evidence demonstrate that overproduction/aggregation of A&#946; in the brain is a primary cause of AD and inhibition of A&#946; generation has become a hot topic in AD research. A&#946; is generated from &#946;-amyloid precursor protein (APP) through sequential cleavages first by &#946;-secretase and then by &#947;-secretase complex. Alternatively, APP can be cleaved by &#945;-secretase within the A&#946; domain to release soluble APP&#945; and preclude A&#946; generation. Cleavage of APP by caspases may also contribute to AD pathologies. Therefore, understanding the metabolism/processing of APP is crucial for AD therapeutics. Here we review current knowledge of APP processing regulation as well as the patho/physiological functions of APP and its metabolites.</description>
        <link>http://www.molecularbrain.com/content/4/1/3</link>
                <dc:creator>Yun-wu Zhang</dc:creator>
                <dc:creator>Robert Thompson</dc:creator>
                <dc:creator>Han Zhang</dc:creator>
                <dc:creator>Huaxi Xu</dc:creator>
                <dc:source>Molecular Brain 2011, null:3</dc:source>
        <dc:date>2011-01-07T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-6606-4-3</dc:identifier>
                                <prism:require>/content/figures/1756-6606-4-3-toc.gif</prism:require>
                <prism:publicationName>Molecular Brain</prism:publicationName>
        <prism:issn>1756-6606</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2011-01-07T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.molecularbrain.com/content/4/1/38">
        <title>Automated 4D analysis of dendritic spine morphology: applications to stimulus-induced spine remodeling and pharmacological rescue in a disease model</title>
        <description>Uncovering the mechanisms that regulate dendritic spine morphology has been limited, in part, by the lack of efficient and unbiased methods for analyzing spines. Here, we describe an automated 3D spine morphometry method and its application to spine remodeling in live neurons and spine abnormalities in a disease model. We anticipate that this approach will advance studies of synapse structure and function in brain development, plasticity, and disease.</description>
        <link>http://www.molecularbrain.com/content/4/1/38</link>
                <dc:creator>Sharon Swanger</dc:creator>
                <dc:creator>Xiaodi Yao</dc:creator>
                <dc:creator>Christina Gross</dc:creator>
                <dc:creator>Gary Bassell</dc:creator>
                <dc:source>Molecular Brain 2011, null:38</dc:source>
        <dc:date>2011-10-07T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-6606-4-38</dc:identifier>
                                <prism:require>/content/figures/1756-6606-4-38-toc.gif</prism:require>
                <prism:publicationName>Molecular Brain</prism:publicationName>
        <prism:issn>1756-6606</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>38</prism:startingPage>
        <prism:publicationDate>2011-10-07T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.molecularbrain.com/content/1/1/6">
        <title>Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders</title>
        <description>Elucidating the neural and genetic factors underlying psychiatric illness is hampered by current methods of clinical diagnosis. The identification and investigation of clinical endophenotypes may be one solution, but represents a considerable challenge in human subjects. Here we report that mice heterozygous for a null mutation of the alpha-isoform of calcium/calmodulin-dependent protein kinase II (alpha-CaMKII+/-) have profoundly dysregulated behaviours and impaired neuronal development in the dentate gyrus (DG). The behavioral abnormalities include a severe working memory deficit and an exaggerated infradian rhythm, which are similar to symptoms seen in schizophrenia, bipolar mood disorder and other psychiatric disorders. Transcriptome analysis of the hippocampus of these mutants revealed that the expression levels of more than 2000 genes were significantly changed. Strikingly, among the 20 most downregulated genes, 5 had highly selective expression in the DG. Whereas BrdU incorporated cells in the mutant mouse DG was increased by more than 50 percent, the number of mature neurons in the DG was dramatically decreased. Morphological and physiological features of the DG neurons in the mutants were strikingly similar to those of immature DG neurons in normal rodents. Moreover, c-Fos expression in the DG after electric footshock was almost completely and selectively abolished in the mutants. Statistical clustering of human post-mortem brains using 10 genes differentially-expressed in the mutant mice were used to classify individuals into two clusters, one of which contained 16 of 18 schizophrenic patients. Nearly half of the differentially-expressed probes in the schizophrenia-enriched cluster encoded genes that are involved in neurogenesis or in neuronal migration/maturation, including calbindin, a marker for mature DG neurons. Based on these results, we propose that an &quot;immature DG&quot; in adulthood might induce alterations in behavior and serve as a promising candidate endophenotype of schizophrenia and other human psychiatric disorders.</description>
        <link>http://www.molecularbrain.com/content/1/1/6</link>
                <dc:creator>Nobuyuki Yamasaki</dc:creator>
                <dc:creator>Motoko Maekawa</dc:creator>
                <dc:creator>Katsunori Kobayashi</dc:creator>
                <dc:creator>Yasushi Kajii</dc:creator>
                <dc:creator>Jun Maeda</dc:creator>
                <dc:creator>Miho Soma</dc:creator>
                <dc:creator>Keizo Takao</dc:creator>
                <dc:creator>Koichi Tanda</dc:creator>
                <dc:creator>Koji Ohira</dc:creator>
                <dc:creator>Keiko Toyama</dc:creator>
                <dc:creator>Kouji Kanzaki</dc:creator>
                <dc:creator>Kohji Fukunaga</dc:creator>
                <dc:creator>Yusuke Sudo</dc:creator>
                <dc:creator>Hiroshi Ichinose</dc:creator>
                <dc:creator>Masashi Ikeda</dc:creator>
                <dc:creator>Nakao Iwata</dc:creator>
                <dc:creator>Norio Ozaki</dc:creator>
                <dc:creator>Hidenori Suzuki</dc:creator>
                <dc:creator>Makoto Higuchi</dc:creator>
                <dc:creator>Tetsuya Suhara</dc:creator>
                <dc:creator>Shigeki Yuasa</dc:creator>
                <dc:creator>Tsuyoshi Miyakawa</dc:creator>
                <dc:source>Molecular Brain 2008, null:6</dc:source>
        <dc:date>2008-09-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-6606-1-6</dc:identifier>
                                <prism:require>/content/figures/1756-6606-1-6-toc.gif</prism:require>
                <prism:publicationName>Molecular Brain</prism:publicationName>
        <prism:issn>1756-6606</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2008-09-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.molecularbrain.com/content/5/1/3">
        <title>Genetic marking and characterization of Tac2-expressing neurons in the central and peripheral nervous system</title>
        <description>Background:
The neurocircuits that process somatic sensory information in the dorsal horn of the spinal cord are still poorly understood, with one reason being the lack of Cre lines for genetically marking or manipulating selective subpopulations of dorsal horn neurons. Here we describe Tac2-Cre mice that were generated to express the Cre recombinase gene from the Tac2 locus. Tachykinin 2 (Tac2) encodes a neurotransmitter, neurokinin B (NKB).
Results:
By crossing Tac2-Cre mice with ROSA26-tdTomato reporter mice, we directly visualized Tac2 lineage neurons in the dorsal root ganglia, the dorsal horn of the spinal cord, and many parts of the brain including the olfactory bulb, cerebral cortex, amygdala, hippocampus, habenula, hypothalamus, and cerebellum. This Tac2-Cre allele itself was a null allele for the Tac2 gene. Behavioral analyses showed that Tac2 homozygous null mice responded normally to a series of algogenic (pain-inducing) and pruritic (itch-inducing) stimuli.
Conclusions:
Tac2-Cre mice are a useful tool to mark specific subsets of neurons in the sensory ganglia, the dorsal spinal cord, and the brain. These mice can also be used for future genetic manipulations to study the functions of Tac2-expressing neurons or the functions of genes expressed in these neurons.</description>
        <link>http://www.molecularbrain.com/content/5/1/3</link>
                <dc:creator>Lynn Mar</dc:creator>
                <dc:creator>Fu-Chia Yang</dc:creator>
                <dc:creator>Qiufu Ma</dc:creator>
                <dc:source>Molecular Brain 2012, null:3</dc:source>
        <dc:date>2012-01-24T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-6606-5-3</dc:identifier>
                                <prism:require>/content/figures/1756-6606-5-3-toc.gif</prism:require>
                <prism:publicationName>Molecular Brain</prism:publicationName>
        <prism:issn>1756-6606</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2012-01-24T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.molecularbrain.com/content/4/1/44">
        <title>Dependence of NMDA/GSK3beta Mediated Metaplasticity on TRPM2 Channels at Hippocampal CA3-CA1 Synapses</title>
        <description>Transient receptor potential melastatin 2 (TRPM2) is a calcium permeable non-selective cation channel that functions as a sensor of cellular redox status.  Highly expressed within the CNS, we have previously demonstrated the functional expression of these channels in CA1 pyramidal neurons of the hippocampus.  Although implicated in oxidative stress-induced neuronal cell death, and potentially in neurodegenerative disease, the physiology of transient receptor potential melastatin 2 channels (TRPM2) is unknown.  Interestingly, we have shown that the activation of these channels may be sensitized by co-incident NMDA receptor activation, suggesting a potential contribution of TRPM2 to synaptic transmission.  Using hippocampal cultures and slices from TRPM2 null mice we demonstrate that the loss of these channels selectively impairs NMDAR-dependent long-term depression (LTD) while sparing long-term potentiation.  Impaired LTD resulted from an inhibition of GSK3beta, through increased phosphorylation, and a reduction in the expression of PSD95 and AMPARs.  Notably, LTD could be rescued in TRPM2 null mice by recruitment of GSK3beta signalling following dopamine D2 receptor stimulation.  We propose that TRPM2 channels play a key role in hippocampal synaptic plasticity.</description>
        <link>http://www.molecularbrain.com/content/4/1/44</link>
                <dc:creator>Yu-Feng Xie</dc:creator>
                <dc:creator>Jillian Belrose</dc:creator>
                <dc:creator>Gang Lei</dc:creator>
                <dc:creator>Michael Tymianski</dc:creator>
                <dc:creator>Yasuo Mori</dc:creator>
                <dc:creator>John MacDonald</dc:creator>
                <dc:creator>Michael Jackson</dc:creator>
                <dc:source>Molecular Brain 2011, null:44</dc:source>
        <dc:date>2011-12-21T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-6606-4-44</dc:identifier>
                                <prism:require>/content/figures/1756-6606-4-44-toc.gif</prism:require>
                <prism:publicationName>Molecular Brain</prism:publicationName>
        <prism:issn>1756-6606</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>44</prism:startingPage>
        <prism:publicationDate>2011-12-21T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.molecularbrain.com/content/4/1/43">
        <title>Neuromelanin, neurotransmitter status and brainstem location determine the differential vulnerability of catecholaminergic neurons to mitochondrial DNA deletions</title>
        <description>Background:
Deletions of the mitochondrial DNA (mtDNA) accumulate to high levels in dopaminergic neurons of the substantia nigra pars compacta (SNc) in normal aging and in patients with Parkinson&apos;s disease (PD). Human nigral neurons characteristically contain the pigment neuromelanin (NM), which is believed to alter the cellular redox-status. The impact of neuronal pigmentation, neurotransmitter status and brainstem location on the susceptibility to mtDNA damage remains unclear. We quantified mtDNA deletions in single pigmented and non-pigmented catecholaminergic, as well as non-catecholaminergic neurons of the human SNc, the ventral tegmental area (VTA) and the locus coeruleus (LC), using laser capture microdissection and single-cell real-time PCR.
Results:
In healthy aged individuals, mtDNA deletion levels were highest in pigmented catecholaminergic neurons (25.2 +/- 14.9%), followed by non-pigmented catecholamergic (18.0 +/- 11.2%) and non-catecholaminergic neurons (12.3 +/- 12.3%; p &lt; 0.001). Within the catecholaminergic population, mtDNA deletion levels were highest in dopaminergic neurons of the SNc (33.9 +/- 21.6%) followed by dopaminergic neurons of the VTA (21.9 +/- 12.3%) and noradrenergic neurons of the LC (11.1 +/- 11.4%; p &lt; 0.001). In PD patients, there was a trend to an elevated mutation load in surviving non-pigmented nigral neurons (27.13 +/- 16.73) compared to age-matched controls (19.15 +/- 11.06; p = 0.052), but levels where similar in pigmented nigral neurons of PD patients (41.62 +/- 19.61) and controls (41.80 +/- 22.62).
Conclusions:
Catecholaminergic brainstem neurons are differentially susceptible to mtDNA damage. Pigmented dopaminergic neurons of the SNc show the highest levels of mtDNA deletions, possibly explaining the exceptional vulnerability of the nigro-striatal system in PD and aging. Although loss of pigmented noradrenergic LC neurons also is an early feature of PD pathology, mtDNA deletion levels are not elevated in this nucleus in healthy controls. Thus, mtDNA deletions are neither an inevitable consequence of catecholamine metabolism nor an universal explanation for the regional vulnerability seen in PD.</description>
        <link>http://www.molecularbrain.com/content/4/1/43</link>
                <dc:creator>Matthias Elstner</dc:creator>
                <dc:creator>Sarina Muller</dc:creator>
                <dc:creator>Lars Leidolt</dc:creator>
                <dc:creator>Christoph Laub</dc:creator>
                <dc:creator>Lena Krieg</dc:creator>
                <dc:creator>Falk Schlaudraff</dc:creator>
                <dc:creator>Birgit Liss</dc:creator>
                <dc:creator>Christopher Morris</dc:creator>
                <dc:creator>Douglass Turnbull</dc:creator>
                <dc:creator>Eliezer Masliah</dc:creator>
                <dc:creator>Holger Prokisch</dc:creator>
                <dc:creator>Thomas Klopstock</dc:creator>
                <dc:creator>Andreas Bender</dc:creator>
                <dc:source>Molecular Brain 2011, null:43</dc:source>
        <dc:date>2011-12-21T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-6606-4-43</dc:identifier>
                                <prism:require>/content/figures/1756-6606-4-43-toc.gif</prism:require>
                <prism:publicationName>Molecular Brain</prism:publicationName>
        <prism:issn>1756-6606</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>43</prism:startingPage>
        <prism:publicationDate>2011-12-21T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.molecularbrain.com/content/5/1/5">
        <title>Hippocampal function is not required for the precision of remote place memory</title>
        <description>Background:
During permanent memory formation, recall of acquired place memories initially depends on the hippocampus and eventually become hippocampus-independent with time. It has been suggested that the quality of original place memories also transforms from a precise form to a less precise form with similar time course. The question arises of whether the quality of original place memories is determined by brain regions on which the memory depends.
Results:
To directly test this idea, we introduced a new procedure: a non-associative place recognition memory test in mice. Combined with genetic and pharmacological approaches, our analyses revealed that place memory is precisely maintained for 28 days, although the recall of place memory shifts from hippocampus-dependent to hippocampus-independent with time. Moreover, the inactivation of the hippocampal function does not inhibit the precision of remote place memory.
Conclusion:
These results indicate that the quality of place memories is not determined by brain regions on which the memory depends.</description>
        <link>http://www.molecularbrain.com/content/5/1/5</link>
                <dc:creator>Takashi Kitamura</dc:creator>
                <dc:creator>Reiko Okubo-suzuki</dc:creator>
                <dc:creator>Noriko Takashima</dc:creator>
                <dc:creator>Akiko Murayama</dc:creator>
                <dc:creator>Toshiaki Hino</dc:creator>
                <dc:creator>Hirofumi Nishizono</dc:creator>
                <dc:creator>Satoshi Kida</dc:creator>
                <dc:creator>Kaoru Inokuchi</dc:creator>
                <dc:source>Molecular Brain 2012, null:5</dc:source>
        <dc:date>2012-02-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-6606-5-5</dc:identifier>
                                <prism:require>/content/figures/1756-6606-5-5-toc.gif</prism:require>
                <prism:publicationName>Molecular Brain</prism:publicationName>
        <prism:issn>1756-6606</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2012-02-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.molecularbrain.com/content/5/1/2">
        <title>Understanding the physiological roles of the neuronal calcium sensor proteins</title>
        <description>Calcium signalling plays a crucial role in the control of neuronal function and plasticity. Changes in neuronal Ca2+ concentration are detected by Ca2+-binding proteins that can interact with and regulate target proteins to modify their function. Members of the neuronal calcium sensor (NCS) protein family have multiple non-redundant roles in the nervous system. Here we review recent advances in the understanding of the physiological roles of the NCS proteins and the molecular basis for their specificity.</description>
        <link>http://www.molecularbrain.com/content/5/1/2</link>
                <dc:creator>Robert Burgoyne</dc:creator>
                <dc:creator>Lee Haynes</dc:creator>
                <dc:source>Molecular Brain 2012, null:2</dc:source>
        <dc:date>2012-01-23T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-6606-5-2</dc:identifier>
                                <prism:require>/content/figures/1756-6606-5-2-toc.gif</prism:require>
                <prism:publicationName>Molecular Brain</prism:publicationName>
        <prism:issn>1756-6606</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>2</prism:startingPage>
        <prism:publicationDate>2012-01-23T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

